1. Rai B, Kharb S, Anand SC. Salivary enzymes and thiocynate:salivary markers of periodontitis among smokers and nonsmokers;
a pilot study. Adv Med Dent Sci. 2007;1(1):1-4.
2. Leite FR, Nascimento GG, Scheutz F, López R. Effect of
smoking on periodontitis: a systematic review and metaregression.
Am J Prev Med. 2018;54(6):831-41. doi: 10.1016/j.
amepre.2018.02.014.
3. Karemore V, Phadnaik M, Desurkar Y, Dashputra A, Chavan B,
Korambeth S. Prevalence of periodontitis in smokers, smokeless
tobacco chewers in central India population. Int J Curr Adv
Res. 2022;11(5):952-5. doi: 10.24327/ijcar.2022.955.0216.
4. Nunn ME. Understanding the etiology of periodontitis: an
overview of periodontal risk factors. Periodontol 2000.
2003;32:11-23. doi: 10.1046/j.0906-6713.2002.03202.x.
5. Eke PI, Dye BA, Wei L, Slade GD, Thornton‐Evans
GO, Borgnakke WS, et al. Update on prevalence of
periodontitis in adults in the United States: NHANES 2009
to 2012. J Periodontol. 2015;86(5):611-22. doi: 10.1902/
jop.2015.140520.
6. Batchelor P. Is periodontal disease a public health problem?
Br Dent J. 2014;217(8):405-9. doi: 10.1038/sj.bdj.2014.912.
7. Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ,
Marcenes W. Global burden of severe periodontitis in 1990-
2010: a systematic review and meta-regression. J Dent Res.
2014;93(11):1045-53. doi: 10.1177/0022034514552491.
8. Bui FQ, Almeida-da-Silva CLC, Huynh B, Trinh A, Liu
J, Woodward J, et al. Association between periodontal
pathogens and systemic disease. Biomed J. 2019;42(1):27-35.
doi: 10.1016/j.bj.2018.12.001.
9. Zhang Y, He J, He B, Huang R, Li M. Effect of tobacco
on periodontal disease and oral cancer. Tob Induc Dis.
2019;17:40. doi: 10.18332/tid/106187.
10. Dias LB, Tonzar TT, dos Santos DR, Souza RO, Ribas TB, de
Freitas Silva L, et al. Salivary biomarkers of cellular damage
and oxidative stress following of lower third molar surgical
removal. Arch Health Invest. 2020;9(1):11-7. doi: 10.21270/
archi.v9i1.4865.
11. Buduneli N. Effects of tobacco smoking on chronic
periodontitis and periodontal treatment. In: Buduneli N, ed.
Pathogenesis and Treatment of Periodontitis. IntechOpen;
2012. p. 81-96.
12. Demirtaş M, Şenel Ü, Yüksel S, Yüksel M. A comparison of
the generation of free radicals in saliva of active and passive
smokers. Turk J Med Sci. 2014;44(2):208-11. doi: 10.3906/
sag-1203-72.
13. Ibraheem LM. Karem B, Dhafer AM. Effect of passive smoking
on the periodontal health status and salivary enzymes
level: a comparative study. Advance Research Journal of
Multidisciplinary Discoveries. 2018;32(9):47-51.
14. Johnson GK, Guthmiller JM. The impact of cigarette smoking
on periodontal disease and treatment. Periodontol 2000.
2007;44:178-94. doi: 10.1111/j.1600-0757.2007.00212.x.
15. Global Adult Tobacco Survey. Fact Sheet. Odisha 2016-17.
Available from: https://tmc.gov.in/images/act/Odisha%20
GATS-2%20Factsheet.pdf.
16. Page RC, Kornman KS. The pathogenesis of human
periodontitis: an introduction. Periodontol 2000. 1997;14:9-
11. doi: 10.1111/j.1600-0757.1997.tb00189.x.
17. Adesakin AM, Elizabeth DB, Opeodu OI, Modupe AO.
Evaluating salivary alkaline phosphatase levels as a
biochemical marker of periodontal disease in periodontal
patients in a tertiary hospital in Nigeria. J Adv Periodontol
Implant Dent. 2016;8(1):19-23. doi: 10.15171/jpid.2016.004.
18. Pooja Umaiyal M, Rajendran D, Ramamurthy J. Analysis
of periodontal status among smokers and non-smokers-a
retrospective study. Int J Dent Oral Sci. 2021;8(6):2894-9.
19. Tobón-Arroyave SI, Jaramillo-González PE, Isaza-Guzmán
DM. Correlation between salivary IL-1beta levels and
periodontal clinical status. Arch Oral Biol. 2008;53(4):346-52.
doi: 10.1016/j.archoralbio.2007.11.005.
20. Malathi N, Mythili S, Vasanthi HR. Salivary diagnostics: a
brief review. Int Sch Res Notices. 2014;2014(1):158786. doi:
10.1155/2014/158786.
21. Chaudhary R, Kumar M. Evaluation of salivary alkaline
phosphatase levels in tobacco users to determine its role as a
biomarker in oral potentially malignant disorders. Int J Health
Sci. 2022;6(S2):796-802. doi: 10.53730/ijhs.v6nS2.5070.
22. Bakhtiari S, Bigom Taheri J, Bakhshi M, Mortazavi H, Shah
Hoseini A, Vahid Dastjerdi E, et al. Effect of vitamin C on
salivary total antioxidant capacity in smokers. Iran J Pharm
Res. 2012;11(4):1045-9.
23. Reznick AZ, Klein I, Eiserich JP, Cross CE, Nagler RM. Inhibition
of oral peroxidase activity by cigarette smoke: in vivo and in
vitro studies. Free Radic Biol Med. 2003;34(3):377-84. doi:
10.1016/s0891-5849(02)01297-2.
24. Abdolsamadi HR, Goodarzi MT, Mortazavi H, Robati M,
Ahmadi-Motemaye F. Comparison of salivary antioxidants in
healthy smoking and non-smoking men. Chang Gung Med J.
2011;34(6):607-11.
25. Pullishery F, Panchmal GS, Siddique S. Salivary thiocyanate,
uric acid and pH as biomarkers of periodontal disease in
tobacco users and non-users- an in-vitro study. J Clin Diagn
Res. 2015;9(7):ZC47-50. doi: 10.7860/jcdr/2015/12783.6203.
26. Arinola OG, Akinosun OM, Olaniyi JA. Passive-and activecigarette
smoking: effects on the levels of antioxidant
vitamins, immunoglobulin classes and acute phase reactants.
Afr J Biotechnol. 2011;10(32):6130-2.
27. Noormohammadi R, Mostanadi M, Rafieyan S, Firoozi P.
Comparative evaluation of salivary levels of malondialdehyde
and lactate dehydrogenase in active and passive smokers. J
Oral Health Oral Epidemiol. 2020;9(4):162-7. doi: 10.22122/
johoe.v9i4.1151.
28. Löe H. The gingival index, the plaque index and the retention
index systems. J Periodontol. 1967;38(6):610-6. doi: 10.1902/
jop.1967.38.6.610.
29. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-
Infirri J. Development of the World Health Organization
(WHO) community periodontal index of treatment needs
(CPITN). Int Dent J. 1982;32(3):281-91.
30. Mulla SA, Bedia AS, Nimmagadda HK, Bedia S, Patil AH.
Evaluation of salivary alkaline phosphatase levels in passive
smokers of different age groups. Cureus. 2023;15(7):e41336.
doi: 10.7759/cureus.41336.
31. Sushmitha M, Preethi M, Sivapathasundaram B. Estimation of
salivary alkaline phosphatase levels in smokers and tobacco
chewers associated with diabetes. Eur J Mol Clin Med.
2020;7:119-28.
32. Ling LJ, Hung SL, Tseng SC, Chen YT, Chi LY, Wu KM, et
al. Association between betel quid chewing, periodontal
status and periodontal pathogens. Oral Microbiol Immunol.
2001;16(6):364-9. doi: 10.1034/j.1399-302x.2001.160608.x.
33. Yordanova M, Shopov N. The effect of smoking on salivary
parameters. Family Medicine and Primary Care: Open Access.
2019;3(2):134. doi: 10.29011.jfoa-134/100034.
34. Vaishnavi Devi B, Leelavathi L. Comparative evaluation
of gingival, periodontal and plaque status in smokers and
smokeless tobacco users. Biosci Biotechnol Res Commun.2020;13(8):167-74. doi: 10.21786/bbrc/13.8/131.
35. World Health Organization, International Agency for
Research on Cancer. IARC monographs on the evaluation of
carcinogenic risk to humans. Vol 83. In: Tobacco Smoke and
Involuntary Smoking. IARC Publications; 2004.
36. Rezaei A, Sariri R. Periodontal status, salivary enzymes
and flow rate in passive smokers. Pharmacologyonline.
2011;3:462-76.
37. Sanders AE, Slade GD, Beck JD, Agústsdóttir H. Secondhand
smoke and periodontal disease: atherosclerosis risk in
communities study. Am J Public Health. 2011;101(Suppl
1):S339-46. doi: 10.2105/ajph.2010.300069.
38. Kulkarni V, Uttamani JR, Bhatavadekar NB. Comparison of
clinical periodontal status among habitual smokeless-tobacco
users and cigarette smokers. Int Dent J. 2016;66(1):29-35. doi:
10.1111/idj.12192.
39. Numabe Y, Hisano A, Kamoi K, Yoshie H, Ito K, Kurihara H.
Analysis of saliva for periodontal diagnosis and monitoring. J
Periodontol. 2004;40:115-9.
)